
Thursday, March 28, 2019—The Food and Drug Administration (FDA) has cleared a novel cranial electrostimulation (CES) device (Cervella; Innovative Neurological Devices, Carmel, IN). Proprietary electro…
Thursday, March 21, 2019—The Food and Drug Administration (FDA) has approved solriamfetol (Sunosi; Jazz Pharmaceuticals, Dublin, Ireland) for the treatment of adults with excessive daytime sleepiness …
March/April 2019—Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
March/April 2019—Sleep characterization in children may have a role in evaluation for risk of impaired development, behavior, mood, and self-regulation.
March/April 2019—Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.
March/April 2019—Elite athletes commonly have sleep disturbances and poor sleep quality made worse by the environmental demands of athletics.
March/April 2019—“If sleep doesn’t serve an absolutely vital function, it is the greatest mistake evolution ever made.”—Allan Rechschaffen, University of Chicago
March/April 2019—Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »